1
/
의
1
AntibodySystem
SKU(재고 관리 코드):DHC98599
Lorvotuzumab mertansine (ADC)
Lorvotuzumab mertansine (ADC)
Catalog No.: DHC98599
| Catalog No. | DHC98599 |
|---|---|
| Product name | Lorvotuzumab mertansine (ADC) |
| Size | 5 mg |
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Description | Lorvotuzumab mertansine is an ADC consisting of an NCAM-directed antibody and DM1, a potent derivative of maytansine, used for the study of several solid tumors and hematological tumors. |
| Form | Liquid |
| Purity | >90% as determined by SEC. |
| Clonality | Monoclonal |
| Target | NCAM |
| Purification | Purified by Ion Exchange Chromatography. |
| Endotoxin level | Please contact with the lab for this information. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| Alternative Names | MGN901, huN901-DM1 |
| Clone ID | Lorvotuzumab mertansine |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
Share
